Horizon thyroid eye disease drug Tepezza priced at USD 14900 per vial Medical Dialogues Bureau22 Jan 2020 4:36 AM Horizon said the drug, Tepezza will earn about $105 million in milestone payments in the first half of 2020. The company last week raised its...